Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lebow

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Advances in Radiation Oncology|March 17, 2025
Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate TherapyEmily S Lebow, Jordan Eichholz, Zhigang Zhang, et al.
Translational Lung Cancer Research|September 12, 2022
Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancerJustin M Haseltine, Michael Offin, Jessica R Flynn, et al.
JAMA Network Open|January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and DurvalumabEmily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic RadiosurgeryBenjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
Advances in Radiation Oncology|April 11, 2025
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung CancerEmily S Lebow, Jordan Eichholz, Lillian Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2021
Modelling of late side-effects following cranial proton beam therapyAlmut Dutz, Armin Lühr, Linda Agolli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastasesEmily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution SeriesLauren Linkowski, Ian Messing, Melanie Berger, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Advances in Radiation Oncology|March 17, 2025
Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate TherapyEmily S Lebow, Jordan Eichholz, Zhigang Zhang, et al.
Translational Lung Cancer Research|September 12, 2022
Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancerJustin M Haseltine, Michael Offin, Jessica R Flynn, et al.
JAMA Network Open|January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and DurvalumabEmily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic RadiosurgeryBenjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
Advances in Radiation Oncology|April 11, 2025
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung CancerEmily S Lebow, Jordan Eichholz, Lillian Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2021
Modelling of late side-effects following cranial proton beam therapyAlmut Dutz, Armin Lühr, Linda Agolli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastasesEmily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution SeriesLauren Linkowski, Ian Messing, Melanie Berger, et al.
Pageof 5